Lurasidone, quetiapine, fluoxetine/olanzapine combo

Lurasidone, quetiapine, fluoxetine/olanzapine combo

• A. Quetiapine, fluoxetine/olanzapine combo
• B. Depressive episode treatment in bipolar disorder
• C. Lewy Body dementia treatment
• D. Adjunctive treatment for MDD

Answer: (B)

The key idea is recognizing treatments that are used specifically for depressive episodes in bipolar disorder. Lurasidone is an atypical antipsychotic approved for bipolar depression and can be used alone or with a mood stabilizer. Quetiapine also has strong evidence and approvals for bipolar depression. The fluoxetine/olanzapine fixed-dose combination (Symbyax) is specifically approved for depressive episodes in bipolar disorder (and for treatment-resistant MDD). When you look at these three drugs together, their shared clinical use is managing depressive episodes within bipolar disorder, which is why this option best fits.

The key idea is recognizing treatments that are used specifically for depressive episodes in bipolar disorder. Lurasidone is an atypical antipsychotic approved for bipolar depression and can be used alone or with a mood stabilizer. Quetiapine also has strong evidence and approvals for bipolar depression. The fluoxetine/olanzapine fixed-dose combination (Symbyax) is specifically approved for depressive episodes in bipolar disorder (and for treatment-resistant MDD). When you look at these three drugs together, their shared clinical use is managing depressive episodes within bipolar disorder, which is why this option best fits.